FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105132 [Registered on: 02/03/2026] Trial Registered Prospectively
Last Modified On: 28/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Two Nasal Medications (Dexmedetomidine and Clonidine) Given Before Anaesthesia to Control Heart Rate and Blood Pressure in Patients Undergoing Surgery. 
Scientific Title of Study   A comparative study of intranasal dexmedetomidine and clonidine using a mucosal atomisation device on hemodynamic response t laryngoscopy during intubation  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anju Merine Sebastian 
Designation  JUNIOR RESIDENT  
Affiliation  Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE 
Address  Department of Anaesthesia , 5th floor, high tech building, Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  7907396835  
Fax    
Email  anjumerinesebastian@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sonal Khatavkar 
Designation  Professor 
Affiliation  Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE 
Address  Department of Anaesthesia , 5th floor, high tech building, Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  9820434472  
Fax    
Email  ksonal0711@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sonal Khatvkar 
Designation  Professor 
Affiliation  Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE 
Address  Department of Anaesthesia , 5th floor, high tech building, Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  9820434472  
Fax    
Email  ksonal0711@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Anju Merine Sebastian 
Address  Department of Anaesthesia , 5th floor, high tech building, Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, Sant Tukaram Nagar, Pimpri, Pune  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ANJU MERINE SEBASTIAN  Dr. D. Y. PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE  Department of anesthesia, 5th floor, Hi-tech buuilding, Dr. D Y Patil medical college, hospital and reseach centre Sant tukaram nagar, pimpri, pune 411018
Pune
MAHARASHTRA 
7907396835

anjumerinesebastian@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics sub-commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  CLONIDINE  intranasal clonidine (3 mcg/kg) administered evenly into both nostrils via a mucosal atomisation device (MAD), with a maximum volume of 0.5ml per nostril, 45 minutes before laryngoscopy. 
Intervention  dexmedetomidine  The intranasal dexmedetomidine (1mcg/kg) was administered evenly into both nostrils using a Mucosal Atomization Device (MAD), with a maximum volume of 0.5 mL per nostril 45 min prior to laryngoscopy. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  18-60 years aged patients
BMI 20-35 kg/m2
ASA I – II
Availability of written informed consent
Hemodynamically stable patients with all routine investigations within normal limits.
 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
to compare the efficacy and safety of intranasal dexmedetomidine versus clonidine in controlling peri-intubation hemodynamic responses and providing adequate preoperative sedation.  T0- baseline vitals before instillation of study drug
T1- 10 min after instillation of study drug
T2- 20 min after instillation of study drug
T3- 30 min after instillation of study drug
T4- 45 min after instillation of study drug
T5 –at the time of laryngoscopy and intubation
T6- 1 min after intubation
T7- 3 min after intubation
T8- 5 min after intubation
T9- 10 min after intubation
 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   22/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective, randomized, double-blind, two-arm parallel clinical trial aims to compare the efficacy and safety of intranasal dexmedetomidine and intranasal clonidine, administered via mucosal atomization device, in attenuating the hemodynamic response to laryngoscopy and endotracheal intubation in adult patients undergoing elective surgery under general anaesthesia. A total of 76 ASA I–II patients aged 18–60 years will be randomly allocated into two groups to receive either intranasal clonidine (3 mcg/kg) or intranasal dexmedetomidine (1 mcg/kg) 45 minutes prior to induction of anaesthesia. Hemodynamic parameters including heart rate and mean arterial pressure will be recorded at predefined intervals before and after intubation. Sedation will be assessed using Ramsay Sedation Score. The primary outcome is the change in mean arterial pressure at 1 minute after intubation compared to baseline. Secondary outcomes include heart rate changes, sedation profile, and incidence of adverse events. The study aims to determine the superior intranasal alpha-2 agonist for blunting the pressor response while maintaining hemodynamic stability and safety. 
Close